Despite this, prostate cancer cells typically express several prostate-specific antigens, such as prostatic acid phosphatase (PAP), prostate-specific antigen (PSA), and prostate-specific membrane antigen (PSMA), which have been used as vaccine targets (18). This evidence concerns the gene ACP3 and prostate carcinoma.